47 research outputs found

    A practical exploration of ontology interoperability

    Get PDF
    ISO Common Logic (CL, ISO/IEC 24707:2007) offers the Semantic Web (SW) a new and powerful dimension in achieving the effective discovery, automation, integration, and reuse across applications, data and knowledge. The paper shows how it is possible to explore such interoperability through small scale exemplar projects. As Conceptual Graphs (CG) is a key technology in CL, we focused on the Amine CG software and for the SW we focused on the Protégé OWL software, exploring the possible mappings between ontologies captured in OWL and in Amine. Through this practical exercise the dimensions and extent of the desired interoperability could be demonstrated. This small but significant experiment provided a practical insight into how CG Tools can actually interoperate towards achieving the wider goal of Ontology interoperability between CL and the SW.</p

    Treatment of Vitamin D Deficiency in Predominantly Hispanic and Black Adolescents: A Randomized Clinical Trial.

    No full text
    Objectives To compare 3 different treatment regimens for Vitamin D deficiency in minority adolescents and to explore factors that impact treatment efficacy. Study design We conducted an 8-week, prospective, open-label, randomized clinical trial in an urban, academic, children\u27s hospital. A total of 183 Vitamin D-deficient adolescents, mean 25-hydroxyVitamin D or 25(OH)D 13.7 ± 3.9 ng/mL; mean age 16.6 ± 2.2 years, were randomized into 3 Vitamin D3 (cholecalciferol) treatment arms: 50 000 IU/wk; 5000 IU/d; and 1000 IU/d. Serum 25(OH)D and Vitamin D binding protein (VDBP) levels were measured pre-and posttreatment; 122 (67%) participants completed posttreatment measures. Complete-case and multiple-imputation, intention-to-treat analyses were performed. Results Mean change in 25(OH)D level posttreatment was significantly different among the 3 arms, 24.9 ± 15.1 vs 21.0 ± 15.2 vs 6.2 ± 6.5 ng/mL, for 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P \u3c.001. Both high-dose treatments were effective in increasing the 25(OH)D level out of deficiency range (≥20 ng/mL) in more than 80% of participants, and 60% remained deficient after low-dose treatment. Only 72%, 56%, and 2% achieved Vitamin D sufficiency (\u3e30 ng/mL) with 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P \u3c.001. Obese participants had substantially less mean change in 25(OH)D level after treatment than normal-weight participants, 13.7 ± 10.7 vs 21.9 ± 16.9 ng/mL, P \u3c.001. Mean baseline VDBP level was almost twice as high in Hispanic compared with black participants (P \u3c.001) and did not alter treatment response or change with treatment. Conclusions Adult-sized adolescents require 8 weeks of high-dose cholecalciferol, at least 5000 IU/d, to correct deficiency. Obese adolescents have poorer response to treatment and may need higher doses than nonobese youth. Hispanic and black adolescents have different VDBP levels but similar treatment responses
    corecore